Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marco F. Moedas"'
Autor:
Florian A Rosenberger, Jia Xin Tang, Kate Sergeant, Marco F Moedas, Charlotte M Zierz, David Moore, Conrad Smith, David Lewis, Nishan Guha, Sila Hopton, Gavin Falkous, Amanda Lam, Angela Pyle, Joanna Poulton, Gráinne S Gorman, Robert W Taylor, Christoph Freyer, Anna Wredenberg
Publikováno v:
Human Molecular Genetics
The SLC25A26 gene encodes a mitochondrial inner membrane carrier that transports S-adenosylmethionine (SAM) into the mitochondrial matrix in exchange for S-adenosylhomocysteine (SAH). SAM is the predominant methyl-group donor for most cellular methyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34ac22914fcbdbb6c7b84c317630ae1
https://pubmed.ncbi.nlm.nih.gov/35024855
https://pubmed.ncbi.nlm.nih.gov/35024855
Publikováno v:
Science Advances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=r3c4b2081b22::18ccf1aeded92b9cd14c638a4de2ff6b
Publikováno v:
Molecular & Cellular Proteomics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=r3c4b2081b22::a49bbf3287b1ee1e2585fcdaa5a0e4d0
Autor:
M.A. Farelo, Ruurdtje Hoekstra, Robert A. F. M. Chamuleau, Ronald J. A. Wanders, Margarida F. B. Silva, Aziza A. A. Adam, Marco F. Moedas, Lodewijk IJlst
Publikováno v:
Analytical biochemistry, 535, 47-55. Academic Press Inc.
Current methodologies for the assessment of urea cycle (UC) enzymatic activity are insufficient to accurately evaluate this pathway in biological specimens where lower UC is expected. Liver cell lines, including HepaRG, have been described to have li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::211ae5a0efcd38015becaf21df3858f3
https://pubmed.ncbi.nlm.nih.gov/28757091
https://pubmed.ncbi.nlm.nih.gov/28757091
Autor:
Margarida F. B. Silva, Lodewijk IJlst, Isabel Tavares de Almeida, Ronald J. A. Wanders, Arno van Cruchten, Luísa Diogo, Marco F. Moedas, Wim Kulik
Publikováno v:
Metabolomics, 12(8). Springer New York
Background Therapeutic administration of the drug valproate (VPA) results in metabolic changes at the hepatic level that have not been fully characterized. Interference of this branched-chain fatty acid with the oxidative metabolism of amino acids ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d875520a256f625215e4b31795c98f02
https://doi.org/10.1007/s11306-016-1091-9
https://doi.org/10.1007/s11306-016-1091-9
Autor:
Ronald Ja Wanders, Marco F. Moedas, Mafalda Farelo, Lodewijk IJlst, Margarida F. B. Silva, Antonina Pereira, João M. Caio
Publikováno v:
Free Radical Biology and Medicine. 120:S108
Nitrogen metabolism in humans, as ureotelic organisms, involves reciprocal implications on mitochondrial function and redox homeostasis. The clinical use of valproic acid (VPA), a lysine deacetylase inhibitor, is potentially associated with undesired
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f815929bb8d39b02b92e919427bd16b
https://doi.org/10.1016/j.freeradbiomed.2018.04.357
https://doi.org/10.1016/j.freeradbiomed.2018.04.357
Autor:
Lodewijk IJlst, R. Castro, A. Van Chruchten, Margarida F. B. Silva, R. J. A. Wanders, Marco F. Moedas, R.H. Houtkooper
Publikováno v:
Toxicology Letters. 238:S321
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8796e98dc67de0c5084bab1bc40c5e67
https://doi.org/10.1016/j.toxlet.2015.08.914
https://doi.org/10.1016/j.toxlet.2015.08.914